Liu Xianping, Li Xiao, Li Jianfeng
Department of Thoracic Surgery, Peking University People's Hospital, Beijing 100044, China.
Zhongguo Fei Ai Za Zhi. 2020 Mar 20;23(3):204-210. doi: 10.3779/j.issn.1009-3419.2020.03.11. Epub 2020 Feb 27.
Thymoma is a potential malignant disease with a recurrence rate of 10% to 30% after complete resection. There is no agreement on the treatment strategy and standard for recurrent thymoma. The treatment methods include reoperation, chemotherapy, radiotherapy, targeted therapy and immunotherapy. In this article, we review the previous literature and summarize the indications, efficacy and prognosis of different treatments for recurrent thymoma, so as to provide some reference for treatment criteria for recurrent thymoma.
胸腺瘤是一种潜在的恶性疾病，完整切除术后复发率为10%至30%。对于复发性胸腺瘤的治疗策略和标准尚无共识。治疗方法包括再次手术、化疗、放疗、靶向治疗和免疫治疗。在本文中，我们回顾既往文献，总结复发性胸腺瘤不同治疗方法的适应证、疗效及预后，以期为复发性胸腺瘤的治疗标准提供一些参考。
